On the basis of our results, wesuggest that DOT1L is a critical indicator of breast cancer aggressiveness thatinduces breast cancer initiation and progression, invasion and metastasis because ofits enhancement function of the CSC and EMT. This evidence concerns the gene DOT1L and breast carcinoma.